Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Endocrinology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Endocrinology Other
    Men Taking ADT at Higher Risk for Heart Disease, Diabetes Regardless of Age - (DGNews)
    Abiraterone Acetate Safe Over Long Term in Patients With Advanced Castration-Resistant Prostate Cancer: Presented at EMUC - (DGDispatch)
    Normal Spermatogenesis in a Man with Mutant Luteinizing Hormone - (N Engl J Med)
    Use of Antipsychotic Medications by Children and Adolescents Associated With Significant Weight Gain - (DGNews)
    Calcium Protocol Prevents Calcium Deficit After Parathyroidectomy: Presented at ACS - (DGDispatch)

    News archive

     Recent webcasts/CME - Endocrinology Other
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Insulin-Dependent Diabetes in Long-Term Care: Practical Considerations
    • Anabolic Therapy for Osteoporosis
      PreAnesthetic Assessment of the Patient with von Hippel-Lindau Syndrome

      Webcasts/CME archive

       Recent cases - Endocrinology Other
        A Case of Pediatric Virilizing Adrenocortical Tumor Resulting in Hypothalamic-pituitary Activation and Central Precocious Puberty Following Surgical Removal
        Adrenal Failure Caused by a Retroperitoneal Malignant Mesothelioma
        Impetigo Herpetiformis During The Puerperium Triggered By Secondary Hypoparathyroidism: A Case Report
        Laparoscopic Resection Of A Large Adrenal Myelolipoma: A Case Report
        Thoracic Spinal Cord Compression Caused by Metastatic Pheochromocytoma

        Cases archive
          




        my personal edition > endocrinology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Hormones May Remain Altered One Year After Oral Contraceptive Discontinuation: Presented at AACE

        By Maggie Schwarz

        WASHINGTON, DC -- May 27, 2005 -- "The sexual dysfunction and androgen insufficiency seen with use of oral contraceptives can remain even a year after stopping the medication," according to Claudia Panzer, MD, a fellow in clinical endocrinology at Boston University Medical Center in Boston, Massachusetts, United States.

        Dr. Panzer and associates studied 102 women reporting sexual dysfunction who were either taking or had taken an oral contraceptive. They presented their findings here May 19th at the American Association of Clinical Endocrinologists (AACE) 14th Annual Meeting and Clinical Congress.

        Oral contraceptives are known to lower serum testosterone levels by decreasing ovarian production of testosterone and raising production of sex hormone-binding globulin (SHBG) from the liver. It has been assumed that these changes are reversible once a woman stops taking an oral contraceptive.

        Dr. Panzer and colleagues noticed that SHBG levels can remain elevated for prolonged periods and decided to investigate SHBG levels after discontinuation of oral contraceptives.

        Twenty-three women who had never taken oral contraceptives served as controls. In 62 women who were currently taking oral contraceptives and 40 women who had recently discontinued taking them, SHBG values were measured at baseline and <90 days, 90 to 180 days, and >180 days after discontinuing oral contraceptives.

        SHBG values in the oral contraceptive user group were seven times higher than those in the control group (mean, 135 +/- 57% vs 19 +/- 16%; P < .01). Despite a decrease in SHBG values after discontinuation of oral contraceptive use, SHBG levels remained elevated in comparison with those in the control group (P < .01 for <90 days; P < .05 for 90 to 180 days; and P < .01 for >180 days).

        Oral contraceptives lower the free androgen index, in part by substantially raising SHBG levels. SHBG levels remained continuously elevated by up to 1 year after discontinuing oral contraceptive use.

        The investigators concluded that hormonal changes induced by oral contraceptives are not immediately reversible after discontinuation of the medication, as previously thought. The free androgen index may remain low for a prolonged period -- in this case, up to a year.


        [Presentation title: Androgen Insufficiency And Oral Contraceptives: A Pathophysiologic Mechanism. AACE: 728.]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send